EyeConic Study for Retinal Dystrophies
This study, called EyeConic, is looking for people with inherited retinal dystrophies (eye conditions that cause vision loss) and healthy volunteers. The goal is to prepare for a future treatment that uses optogenetics to restore vision by making dormant (inactive) cone cells in the eye sensitive to light again. Researchers want to find out how many people with low vision still have these dormant cone cells. You would have an optical coherence tomography (OCT) scan, which is a special eye scan. This study is currently unclear on its recruitment status and aims to enroll 1000 participants.
- Study design
- This is an observational study involving 1000 planned participants. It includes both patients with inherited retinal dystrophies and healthy controls.
- What's involved
- You would need to have an optical coherence tomography (OCT) scan of your macula, which takes about 10 minutes at baseline.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
EyeConic: Qualification for Cone-Optogenetics
At a glance
Conditions
Where it's being run
9 sites across 9 statesStudy leadership
- Nicolas Feltgen, MD · PRINCIPAL_INVESTIGATOR · University Hospital Basel/Institute of Molecular and Clinical Ophthalmology Basel, Switzerland
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- OCT - Central retinal volumeBaseline (about 10 minutes)
Number of participants with preserved central retinal volume